Login / Signup

Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting.

Eli R AbernethyGavin P CampbellRachel S HianikMary Catherine ThomsonShannon M BleeHannah Claire SiboldMargie D DixonJeffrey M SwitchenkoRebecca D Pentz
Published in: Cancer (2021)
Therapeutic misconception (TM) refers to research subjects' failure to distinguish the goals of clinical research from standard personal care. TM signals a basic misunderstanding of the purpose of clinical research, threatening valid informed consent to participate in clinical trials. TM has traditionally been determined by questioning patients about their research study's purpose. Recent research, however, has questioned whether TM is as prevalent due to discrepancies between patient/researcher interpretations of TM questions. By developing an interview-tool receptive to these advancements, we report a lower TM estimate in the phase 1 setting (12%) than we found previously in a similar cohort (68%).
Keyphrases
  • clinical trial
  • healthcare
  • newly diagnosed
  • ejection fraction
  • randomized controlled trial
  • case report
  • public health
  • quality improvement
  • patient reported outcomes
  • chronic pain
  • open label